pre-IPO PHARMA

renovacor PRESS RELEASE ARCHIVE

Sep 20, 2022

Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy


Sep 2, 2021

Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange


Aug 25, 2021

Renovacor Announces the Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer


Jul 19, 2021

Renovacor Announces the Appointment of Elizabeth White, Ph.D., as Chief Business Officer and Senior Vice President of Operations


Jul 12, 2021

Renovacor Announces the Appointment of Jiwen Zhang, Ph.D., as Senior Vice President, Regulatory Affairs and Quality Assurance



Jun 29, 2021

Renovacor Announces the Appointments of Joan Lau, Ph.D., and Gregory F. Covino to its Board of Directors


Jun 29, 2021

Renovacor Announces the Appointments of Joan Lau, Ph.D., and Gregory F. Covino to its Board of Directors


Jun 2, 2021

Renovacor Announces the Appointment of Marc Semigran, M.D., as Chief Medical Officer


Jun 2, 2021

Renovacor Announces the Appointment of Marc Semigran, M.D., as Chief Medical Officer


Mar 23, 2021

Renovacor, Inc. to Merge with Chardan Healthcare Acquisition 2 Corp.



Mar 7, 2018

Renovacor Wins “Best In Show” at 1st Pitch Life Science Competition


Google Analytics Alternative